These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 7908156)

  • 1. A self-report Insight Scale for psychosis: reliability, validity and sensitivity to change.
    Birchwood M; Smith J; Drury V; Healy J; Macmillan F; Slade M
    Acta Psychiatr Scand; 1994 Jan; 89(1):62-7. PubMed ID: 7908156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A self-administered instrument to measure psychiatric discomfort of persons with serious mental illness.
    Betemps EJ
    Psychiatr Serv; 1999 Jan; 50(1):107-8. PubMed ID: 9890591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insight correlates in child- and adolescent-onset first episodes of psychosis: results from the CAFEPS study.
    Parellada M; Fraguas D; Bombín I; Otero S; Castro-Fornieles J; Baeza I; Gonzalez-Pinto A; Graell M; Soutullo C; Paya B; Arango C
    Psychol Med; 2009 Sep; 39(9):1433-45. PubMed ID: 19091160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of insight in patients with bipolar disorder: are self-rated scales developed for patients with schizophrenia applicable?
    Jónsdóttir H; Engh JA; Friis S; Birkenaes A; Ringen PA; Vaskinn A; Sundet K; Opjordsmoen S; Andreassen OA
    J Nerv Ment Dis; 2008 Apr; 196(4):333-5. PubMed ID: 18414129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large-scale validation study of the Medication Adherence Rating Scale (MARS).
    Fialko L; Garety PA; Kuipers E; Dunn G; Bebbington PE; Fowler D; Freeman D
    Schizophr Res; 2008 Mar; 100(1-3):53-9. PubMed ID: 18083007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The VAGUS insight into psychosis scale--self-report and clinician-rated versions.
    Gerretsen P; Remington G; Borlido C; Quilty L; Hassan S; Polsinelli G; Teo C; Mar W; Simon R; Menon M; Pothier DD; Nakajima S; Caravaggio F; Mamo DC; Rajji TK; Mulsant BH; Deluca V; Ganguli R; Pollock BG; Graff-Guerrero A
    Psychiatry Res; 2014 Dec; 220(3):1084-9. PubMed ID: 25246410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Subjective Experiences of Psychosis Scale (SEPS): psychometric evaluation of a scale to assess outcome in psychosis.
    Haddock G; Wood L; Watts R; Dunn G; Morrison AP; Price J
    Schizophr Res; 2011 Dec; 133(1-3):244-9. PubMed ID: 22000941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of insight in psychosis.
    Amador XF; Strauss DH; Yale SA; Flaum MM; Endicott J; Gorman JM
    Am J Psychiatry; 1993 Jun; 150(6):873-9. PubMed ID: 8494061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The reliability of DSM-III prodromal symptoms in first-episode psychotic patients.
    Jackson HJ; McGorry PD; McKenzie D
    Acta Psychiatr Scand; 1994 Nov; 90(5):375-8. PubMed ID: 7872043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Royal Park Multidiagnostic Instrument for Psychosis: Part II. Development, reliability, and validity.
    McGorry PD; Singh BS; Copolov DL; Kaplan I; Dossetor CR; van Riel RJ
    Schizophr Bull; 1990; 16(3):517-36. PubMed ID: 2287937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight in early psychosis: a 1-year follow-up.
    Mintz AR; Addington J; Addington D
    Schizophr Res; 2004 Apr; 67(2-3):213-7. PubMed ID: 14984880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM; Cellar JS; Bowers MB; Nelson JC; Takeshita J; Zigun B
    J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Basel Screening Instrument for Psychosis (BSIP): development, structure, reliability and validity].
    Riecher-Rössler A; Aston J; Ventura J; Merlo M; Borgwardt S; Gschwandtner U; Stieglitz RD
    Fortschr Neurol Psychiatr; 2008 Apr; 76(4):207-16. PubMed ID: 18393134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between insight and self-reported quality of life among shizophrenic patients].
    Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
    Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight in psychosis: influence of cognitive ability and self-esteem.
    Cooke MA; Peters ER; Greenwood KE; Fisher PL; Kumari V; Kuipers E
    Br J Psychiatry; 2007 Sep; 191():234-7. PubMed ID: 17766764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Psychotic Symptom Rating Scales (PSYRATS): their usefulness and properties in first episode psychosis.
    Drake R; Haddock G; Tarrier N; Bentall R; Lewis S
    Schizophr Res; 2007 Jan; 89(1-3):119-22. PubMed ID: 17095193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Awareness of being a patient and its relevance to insight into illness in patients with schizophrenia.
    Hayashi N; Yamashina M; Igarashi Y
    Compr Psychiatry; 1999; 40(5):377-85. PubMed ID: 10509621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new instrument for measuring insight: the Beck Cognitive Insight Scale.
    Beck AT; Baruch E; Balter JM; Steer RA; Warman DM
    Schizophr Res; 2004 Jun; 68(2-3):319-29. PubMed ID: 15099613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The voices acceptance and action scale (VAAS): Pilot data.
    Shawyer F; Ratcliff K; Mackinnon A; Farhall J; Hayes SC; Copolov D
    J Clin Psychol; 2007 Jun; 63(6):593-606. PubMed ID: 17457846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.